IP68: Prostate Cancer: Localized: Surgical Therapy III
Sunday, May 17, 2026 3:30 PM to 5:30 PM · 2 hr. (America/New_York)
146A
Poster and Podium Sessions
Oncology: Prostate
Sunday, May 17
IP68-01: Urinary adverse events after robot-assisted versus non-robotic radical prostatectomy in Medicare beneficiaries
Sunday, May 17, 2026 3:30 PM to 5:30 PM
146A
IP68-02: Locally Deployed Large Language Model Achieves Expert-Level Abstraction of Radical Prostatectomy Pathology Across 17 Variables
Sunday, May 17, 2026 3:30 PM to 5:30 PM
146A
IP68-03: Nomogram-Based Prediction of Extraprostatic Extension in Robotic Radical Prostatectomy
Sunday, May 17, 2026 3:30 PM to 5:30 PM
146A
IP68-04: Comparative experience with three robotic platforms for radical prostatectomy: Da Vinci Xi, Medtronic Hugo™ RAS and Da Vinci Single Port
Sunday, May 17, 2026 3:30 PM to 5:30 PM
146A
IP68-05: UPDATED OUTCOMES OF TRANSVESICAL SINGLE-PORT ROBOTIC RADICAL PROSTATECTOMY
Sunday, May 17, 2026 3:30 PM to 5:30 PM
146A
IP68-06: Quantifying the Impact of Biochemical Recurrence After Radical Prostatectomy on Overall Mortality by Years of Life Lost: Results from the SEARCH Database
Sunday, May 17, 2026 3:30 PM to 5:30 PM
146A
IP68-07: Clipless Robotic-Assisted Radical Prostatectomy: A 10-Year Single- Center Analysis of Oncologic and Functional Outcomes
Sunday, May 17, 2026 3:30 PM to 5:30 PM
146A
IP68-08: Radical Assisted Robotic Prostatectomy with Concomitant Inguinal Hernia Repair: 10 years’ experience.
Sunday, May 17, 2026 3:30 PM to 5:30 PM
146A
IP68-09: Impact of Changes in Blood Flow within the Neurovascular Bundle on Early Postoperative Lower Urinary Tract Symptoms Following Robot-Assisted Radical Prostatectomy
Sunday, May 17, 2026 3:30 PM to 5:30 PM
146A
IP68-10: Long-term Oncological Outcomes of Menon Precision Prostatectomy: A 10-year Experience
Sunday, May 17, 2026 3:30 PM to 5:30 PM
146A
IP68-11: Nomogram-Guided Omission of Pelvic Lymph Node Dissection at Robotic Radical Prostatectomy: What Are We Really Missing?
Sunday, May 17, 2026 3:30 PM to 5:30 PM
146A
Umberto Anceschi · IRCSS "regina Elena" National Cancer Institute
IP68-12: Use of Intraoperative Dynamic 3-Dimensional Modeling to Reduce Final Positive Margin Rate After Robot-Assisted Radical Prostatectomy
Sunday, May 17, 2026 3:30 PM to 5:30 PM
146A
IP68-13: The number of cancer-involved regions in patients with prostate cancer diagnosed by MRI/ultrasound-guided fusion prostate biopsy is a new tumor metric associated with increased risk of adverse pathology at radical prostatectomy.
Sunday, May 17, 2026 3:30 PM to 5:30 PM
146A
IP68-14: Early Continence Recovery after Hugo™ RAS Radical Prostatectomy: Evidence from the Italian Multicentre Experience
Sunday, May 17, 2026 3:30 PM to 5:30 PM
146A
IP68-15: Development and internal validation of a nomogram to predict extra-capsular prostate cancer extension in patients with capsular contact at preoperative multiparametric magnetic resonance imaging
Sunday, May 17, 2026 3:30 PM to 5:30 PM
146A
Yusuf Ahmed
IP68-16: Oncological outcomes of robot-assisted radical prostatectomy in International Society of Urological Pathology Grade 5prostate cancer: 10-years follow up
Sunday, May 17, 2026 3:30 PM to 5:30 PM
146A
IP68-17: Optimizing Care for the Frail: Single-Port Radical Prostatectomy Reduces Morbidity vs Multi-Port
Sunday, May 17, 2026 3:30 PM to 5:30 PM
146A
IP68-18: Comparison Between Single-Port and Multi-Port Robotic-Assisted Radical Prostatectomy: A Systematic Review and Meta-Analysis
Sunday, May 17, 2026 3:30 PM to 5:30 PM
146A
IP68-19: Preoperative Predictors of Immediate Urine Continence Following Single Port Transvesical Robotic Radical Prostatectomy
Sunday, May 17, 2026 3:30 PM to 5:30 PM
146A
IP68-20: Safety and perioperative outcomes of extraperitoneal and transperitoneal robot-assisted radical prostatectomy: Multi-institutional propensity score analysis
Sunday, May 17, 2026 3:30 PM to 5:30 PM
146A
Atsushi Igarashi
IP68-21: Outcomes of Gasless Robotic Prostatectomy Performed without Pneumoperitoneum
Sunday, May 17, 2026 3:30 PM to 5:30 PM
146A
IP68-22: Could the preoperative urethral curve be used to predict immediate urinary continence following retzius-sparing robot-assisted radical prostatectomy?
Sunday, May 17, 2026 3:30 PM to 5:30 PM
146A
IP68-23: NCCN Risk Groups Do Not Predict Adverse Pathology or Oncologic Outcomes Among Patients with Grade Group 1 Prostate Cancer Undergoing Radical Prostatectomy in the Contemporary MRI Era
Sunday, May 17, 2026 3:30 PM to 5:30 PM
146A
IP68-24: Is Biopsy ISUP Grade Group 1 a Reliable Indicator of Low-Risk Prostate Cancer?
Sunday, May 17, 2026 3:30 PM to 5:30 PM
146A
IP68-25: Preoperative MRI Features Predict Adverse Pathology and Long-term Outcomes After Radical Prostatectomy: A Prospective Cohort Analysis
Sunday, May 17, 2026 3:30 PM to 5:30 PM
146A
IP68-26: Incorporating PSMA PET/CT Parameters into Clinicopathologic Nomograms for Predicting Lymph Node Involvement in Intermediate- and High-Risk Prostate Cancer
Sunday, May 17, 2026 3:30 PM to 5:30 PM
146A
IP68-27: Assessing the Impact of BMI on Oncological Outcomes and Postoperative Testosterone Recovery Following Robot-Assisted Radical Prostatectomy
Sunday, May 17, 2026 3:30 PM to 5:30 PM
146A
IP68-28: Differential Impact of the SAFE Technique Across Nerve-Sparing Grades in Robotic Radical Prostatectomy: Subanalysis of Interim Outcomes From a Randomized Controlled Trial
Sunday, May 17, 2026 3:30 PM to 5:30 PM
146A
IP68-29: Impact of High Tumor Grade on Prognosis in Organ-Confined Prostate Adenocarcinoma Undergoing Surgical Resection
Sunday, May 17, 2026 3:30 PM to 5:30 PM
146A
IP68-30: The Role of Sexual Interest in Sexual Function Outcomes in Men Undergoing Treatment for Localized Prostate Cancer: Results From an International Cohort
Sunday, May 17, 2026 3:30 PM to 5:30 PM
146A
Registered attendees
KS
Kristian Stensland
Assistant ProfessorUniversity of Michigan